title: Neutral endopeptidase modulates neurotensin-induced airway contraction.
abstract: To determine the role of endogenous neutral endopeptidase (NEP) (also called enkephalinase, EC 3.4.24.11) in regulating neurotensin-induced airway contraction, we used phosphoramidon, a specific NEP inhibitor, in the guinea pig. In studies in vitro, neurotensin and the COOH-terminal fragment neurotensin-(8-13) contracted strips of bronchial smooth muscle in a concentration-dependent fashion (P less than 0.001). In contrast, the NH2-terminal fragment neurotensin-(1-11) and the COOH-terminal fragment neurotensin-(12-13), the main fragments of neurotensin hydrolysis by NEP, had no effect. Phosphoramidon (10(-5) M) did not change resting tension but shifted the concentration-response curves to neurotensin to lower concentrations (P less than 0.001), whereas inhibitors of kininase II, aminopeptidases, serine proteases, and carboxypeptidase N were without effect. Removing the epithelium increased the contractile response to neurotensin (P less than 0.001), and phosphoramidon further increased the response to neurotensin in these tissues (P less than 0.001). Similar results were obtained in studies in vivo using aerosolized neurotensin and phosphoramidon. These results suggest that endogenous NEP in the airways modulates the effects of neurotensin on airway smooth muscle contraction by inactivating the peptide.
authors.affiliation: Cardiovascular Research Institute, University of California, San Francisco 94143.
authors.forename: T D
authors.initials: TD
authors.lastname: Djokic
authors.forename: D J
authors.initials: DJ
authors.lastname: Dusser
authors.forename: D B
authors.initials: DB
authors.lastname: Borson
authors.forename: J A
authors.initials: JA
authors.lastname: Nadel
mesh_terms: D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects*; D000818:Animals; D001980:Bronchi / Q000187:drug effects / Q000502:physiology*; D004848:Epithelium / Q000502:physiology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D015260:Neprilysin / Q000378:metabolism*; D009496:Neurotensin / Q000008:administration & dosage / Q000494:pharmacology*; D012016:Reference Values
chemical_list: D000336:Aerosols; D009496:Neurotensin; D015260:Neprilysin